Robert Gagel, MD, Chair: Dr. Gagel is a Professor of Medicine at MD Anderson Cancer Center where he served as Head of Endocrine Neoplasia and Head of Internal Medicine. He is a graduate of Ohio State University College of Medicine, did clinical training in Internal Medicine and Endocrinology and Metabolism at Tufts-New England Medical Center and a postdoctoral research fellowship at Harvard Medical School. He has been a faculty member at Baylor College of Medicine and MD Anderson Cancer Center. His major research accomplishments include a leadership role in the management of multiple endocrine neoplasia types 1 and 2, elucidation of the pathways by which mutations of the RET proto-oncogene cause medullary thyroid carcinoma and development of therapies based on this information, definition of the physiologic role of calcitonin and identification of mutations of the sulfonylurea receptor as the cause of persistent hypoglycemia of infancy.

Susan Greenspan, MD, President: Dr. Greenspan has held multiple roles at the University of Pittsburgh since 1999, including Professor of Medicine and Director of the Osteoporosis Prevention and Treatment Center. She is also the Director of the Bone Health Program at Magee Women’s Hospital and Program Director of the Clinical Translational Research Center at the University of Pittsburgh Medical Center. Dr. Susan Greenspan received her undergraduate degree from Stanford University and her MD from Harvard Medical School, where after training in Endocrinology and Geriatrics, she joined the faculty and founded and directed the Osteoporosis Center.

Dr. Greenspan’s NIH-funded research centers on osteoporosis in elderly men and women and has covered topics including new therapies for osteoporosis; new ways to diagnose, assess, and monitor bone loss; and bone loss in women with breast cancer and men with prostate cancer. Dr. Greenspan co-authored the U.S. Surgeon General’s report on Osteoporosis and has authored more than 150 peer reviewed articles and invited papers. She has served on the Scientific Advisory Boards for NOF and the International Society for Clinical Densitometry as well as several editorial boards of scientific journals. She was a council member of the American Society of Bone and Mineral Research from 2002-2005 and program chair for the 2006 annual meeting of the American Society of Bone and Mineral Research. She has also been featured in Best Doctors in America, Best Doctors in Pittsburgh and America’s Top Doctors.

E. Michael Lewiecki, MD, FACP, FACE, Vice President: Dr. Lewiecki is a Clinical Assistant Professor of Medicine at University of New Mexico School of Medicine and Director of New Mexico Clinical Research & Osteoporosis Center in Albuquerque, NM. He is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies at his center, and an educator with a special interest in osteoporosis, metabolic bone disease, and bone densitometry. He is principal investigator for the center’s osteoporosis clinical trials and author of many peer-reviewed scientific publications on osteoporosis and bone densitometry. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD). He is a faculty member for ISCD-IOF educational programs, senior editor of Clinical Investigation, associate editor for Journal of Clinical Densitometry, and editorial board member of other journals, including Osteoporosis International. He is the founder and current president of the Osteoporosis Foundation of New Mexico and director of its educational activities. He established and is program director of the annual Santa Fe Bone Symposium. is Clinical Assistant Professor of Medicine at University of New Mexico School of Medicine and Director of New Mexico Clinical Research & Osteoporosis Center in Albuquerque, NM. He is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies at his center, and an educator with a special interest in osteoporosis, metabolic bone disease, and bone densitometry. He is principal investigator for the center’s osteoporosis clinical trials and author of many peer-reviewed scientific publications on osteoporosis and bone densitometry. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD). He is a faculty member for ISCD-IOF educational programs, senior editor of Clinical Investigation, associate editor for Journal of Clinical Densitometry, and editorial board member of other journals, including Osteoporosis International. He is the founder and current president of the Osteoporosis Foundation of New Mexico and director of its educational activities. He established and is program director of the annual Santa Fe Bone Symposium.

Barbara Hannah Grufferman, Secretary and Interim Treasurer:  Ms. Grufferman​ is ​a ​nationally ​recognized advocate for positive living​. Dr. Mehmet Oz said of her previous book, The Best of Everything After 50: “Every once in a while a book comes across your desk, and you just have to pick it up. This is one of them!” ​She is a frequent contributor to HuffPost and AARP, has appeared on the Today Show, CBS Morning Show, Good Morning America, The Doctors, The Talk, Dr. Phil, NPR, The Dr. Oz Show on Sirius Radio and ​OWN, ​the Oprah Channel, any many local radio and TV shows. Barbara travels around the country speaking to groups on health, nutrition, career, fitness, sex and many other topics related to positive and healthy aging. She ​is a recipient of the Generations of Strength Award from the National Osteoporosis Foundation for her outspoken support of positive and healthy aging in America​, and also serves as Bone Health Ambassador and trustee. Ms. Grufferman, a proud mother of two daughters, lives in New York City with her husband and rescued dog. A passionate knitter and runner, Ms. Grufferman has completed four New York City Marathons, one Edinburgh Marathon, and one Ultramarathon.

Download Acrobat Reader